Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Semaglutide biosimilar by Leto Laboratories for Diabetes: Likelihood of Approval
Semaglutide biosimilar is under clinical development by Leto Laboratories and currently in Phase II for Diabetes. According to GlobalData, Phase...